Sign in

CIK 0000925741

  • Non-accelerated filer
  • Smaller reporting company

BioCardia, Inc.

Sign in to watch
Ticker
BCDA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
232753988
Phone
+1 650-226-0123
Business address
320 SOQUEL WAY, SUNNYVALE, CA, 94085
Former names
Tiger X Medical, Inc., Cardo Medical, Inc., CLICKNSETTLE COM INC, NAM CORP
  1. 4 Open-market buy President and CEO bought 6,200 shares at $1.60 ($9,920)
  2. 4 Grant or award Senior Vice President, Devices acquired 40,490 shares (grant or award)
  3. 4 Grant or award Chief Financial Officer acquired 61,389 shares (grant or award)
  4. 4 Grant or award President and CEO acquired 109,324 shares (grant or award)
  5. 4 Derivatives Options or other derivatives
  6. 4/A Grant or award President and CEO acquired 3,498 shares (grant or award)
  7. 4 Open-market buy President and CEO bought 100 shares at $1.87 ($187)
  8. 4/A Grant or award Chief Financial Officer acquired 17,347 shares (grant or award)
  9. 4/A Shares withheld for taxes President and CEO gave up 26,458 shares (to pay taxes)
  10. 4 Open-market buy 10% owner bought 595,238 shares at $1.68 ($1,000,000)
  11. 4 Grant or award Director acquired 148,809 shares (grant or award)
  12. 4 Grant or award Director acquired 148,809 shares (grant or award)
  13. 4 Grant or award President and CEO acquired 14,880 shares (grant or award)
  14. 4 Grant or award Director acquired 178,571 shares (grant or award)
  15. 4 Grant or award Chief Financial Officer acquired 8,928 shares (grant or award)
  16. 4 Open-market buy President and CEO bought 4,500 shares at an average $1.87 ($8,401)
  17. 4 Open-market buy Chief Financial Officer bought 2,000 shares at $2.07 ($4,140)
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 7 of 23 · 442 filings